BDSX Q4 2022 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$10M+33.0% YoY

Gross Profit

$6M65.6% margin

Operating Income

-$14M-144.6% margin

Net Income

-$20M-211.7% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-13.5%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$93M

Total Liabilities

$72M

Stockholders' Equity

$21M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+33.0%
Gross Profit	$6M	$5M	+33.2%
Operating Income	-$14M	-$12M	-18.9%
Net Income	-$20M	-$13M	-53.1%

Revenue Segments

Diagnostic Tests

$8M86%

Service

$1M14%